{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:20:43Z","timestamp":1793924443444,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neurobiolaging.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:24:20Z","timestamp":1771604660000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neurotransmitter landscape and neurodegeneration patterns in Alzheimer\u2019s Disease"],"prefix":"10.1016","volume":"162","author":[{"given":"Lucia","family":"Argenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Peira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sofia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmario","family":"Sambuceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garbarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Kreshpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pelagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gualco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Cirone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Francia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brugnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Girtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Roccatagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Piana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Serrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Uccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chincarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Orso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib1","first-page":"235","article-title":"Noncanonical metabotropic glutamate receptor 5 signaling in Alzheimer\u2019s disease","volume":"61","author":"Abd-Elrahman","year":"2021","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner","volume":"13","author":"Abd-Elrahman","year":"2020","journal-title":"Sci. Signal"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib3","article-title":"Glucose metabolism alterations and A\u03b2 deposition in AD and FTD are related to the distribution of neurotransmitter systems","author":"Bi","year":"2025","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/brain\/116.3.497","article-title":"Loss of brain 5-HT2 receptors in Alzheimer\u2019s disease: in vivo assessment with positron emission tomography and (18) setoperone","volume":"116","author":"Blin","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib6","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s00259-023-06132-4","article-title":"Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways","volume":"50","author":"Boccalini","year":"2023","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cortex.2023.11.011","article-title":"Tracking the progression of Alzheimer\u2019s disease: insights from metabolic patterns of SOMI stages","volume":"171","author":"Brugnolo","year":"2024","journal-title":"Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib8","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/alz.074620","article-title":"Quantification supports visual assessment of challenging amyloid-PET images","volume":"19","author":"Collij","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0028-3908(95)00085-K","article-title":"Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5","volume":"34","author":"Daggett","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","article-title":"A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia","volume":"12","author":"Della Rosa","year":"2014","journal-title":"Neuroinformatics"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hbm.25244","article-title":"JuSpace: a tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps","volume":"42","author":"Dukart","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3","volume":"49","author":"Guedj","year":"2022","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/brain\/awv356","article-title":"Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer\u2019s disease","volume":"139","author":"Haas","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86085","article-title":"Resting-state alterations in behavioral variant frontotemporal dementia are related to the distribution of monoamine and GABA neurotransmitter systems","volume":"13","author":"Hahn","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1756-6606-7-40","article-title":"Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer\u2019s disease","volume":"7","author":"Hamilton","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/alz.12316","article-title":"The Alzheimer\u2019s Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid \u03b2 and tau","volume":"17","author":"Hansson","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3233\/JAD-2010-100117","article-title":"Plaque deposition dependent decrease in 5-HT2A serotonin receptor in A\u03b2PPswe\/PS1dE9 amyloid overexpressing mice","volume":"20","author":"Holm","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib20","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.archger.2011.10.013","article-title":"Topography of cortical thinning areas associated with hippocampal atrophy in patients with Alzheimer\u2019s disease","volume":"54","author":"Kim","year":"2012","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-004-2077-2","article-title":"Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer\u2019s disease","volume":"179","author":"Lai","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00259-024-06862-z","article-title":"Loss of synaptic density in nucleus basalis of Meynert indicates distinct neurodegeneration in Alzheimer\u2019s disease: the RJNB-D study","volume":"52","author":"Li","year":"2024","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13286","article-title":"Antiallergic drug desloratadine as a selective antagonist of 5-HT2A receptor ameliorates pathology of Alzheimer\u2019s disease model mice by improving microglial dysfunction","volume":"20","author":"Lu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neurobiolaging.2022.03.019","article-title":"Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer\u2019s disease: preliminary data","volume":"117","author":"Massa","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-020-0582-0","article-title":"PET imaging of mGluR5 in Alzheimer\u2019s disease","volume":"12","author":"Mecca","year":"2020","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106897","article-title":"Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: whole-brain MRI analysis","volume":"209","author":"Morais","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib29","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1074\/jbc.271.8.4188","article-title":"Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion","volume":"271","author":"Nitsch","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib30","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/hbm.26206","article-title":"Unravelling neurotransmitters impairment in primary progressive aphasias","volume":"44","author":"Premi","year":"2023","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid \u03b2 oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.06.010","article-title":"The serotonergic system in ageing and Alzheimer\u2019s disease","volume":"99","author":"Rodr\u00edguez","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00221-013-3818-4","article-title":"The role of serotonin in memory: interactions with neurotransmitters and downstream signaling","volume":"232","author":"Seyedabadi","year":"2014","journal-title":"Exp. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148797","article-title":"The neurotransmitter puzzle of Alzheimer\u2019s: dissecting mechanisms and exploring therapeutic horizons","volume":"1829","author":"Sharma","year":"2024","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u2019s disease","volume":"151","author":"\u0160imi\u0107","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa2034634","article-title":"Trial of pimavanserin in dementia-related psychosis","volume":"385","author":"Tariot","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease: translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib39","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2026.02.004_bib40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:27:48Z","timestamp":1781857668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0197458026000254"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.02.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurotransmitter landscape and neurodegeneration patterns in Alzheimer\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}